AB Science SA Sustainability Reports
AB Science S.A. specializes in the research, development, and commercialization of protein kinase inhibitors for treating cancerous tumors, inflammatory conditions, and neurodegenerative diseases. Its primary product pipeline focuses on targeted therapies for both human and veterinary medicine.
Sector: Professional & technical services
Country: France
Exchange: Euronext Paris
LEI: 969500U43TVR8CCVBJ97
FIGI: BBG001T887L1
12 reports from 2014 to 2025
